drug diversion prevention policyDrug diversion in the healthcare system leads to serious safety issues to both the patients and health care workers as well as placing significant liability on the facility. Diversion of controlled substances (CS) in health care settings creates multiple victims, leading to inadequate documentation of a patient’s care, inadequate pain relief and exposure to infectious diseases.  An effective drug diversion prevention policy is necessary to protect patients, workers and healthcare facilities.

Healthcare organizations must evaluate their drug diversion policy for gaps in detection and prevention.  Leadership, internal auditors and compliance within healthcare organizations must all come together for an effective drug diversion policy.  The DEA and EPA both provide guidelines to follow for compliant pharmaceutical management and waste disposal.  Managing controlled substances with a strictly followed Chain of Custody is imperative, along with carefully followed and documented drug disposal procedures. 

Steps to Establish an Effective Drug Diversion Policy

Here are some of the most important steps in establishing an effective drug diversion policy:

1)  Identify where drug diversion can occur in your healthcare environment.

Healthcare organizations must incorporate many functions efficiently to prevent drug diversion.  These functions include an interdisciplinary approach to:

  • Accountability
  • Technology
  • Significant controls
  • Monitoring
  • Surveillance
  • Training

Policies and procedures may differ from small facilities to large metropolitan hospitals, with varying operating budgets and resources.  Healthcare facilities must implement monitoring and surveillance from procurement to pharmaceutical waste disposal of controlled substances for effective prevention of drug diversion.

2)  Identify healthcare workers at risk for drug diversion.

Organizations must identify workers at risk for drug diversion of controlled substances and put practices in place for improved screening and identification.  Risk factors include people who obtain overlapping prescriptions from multiple pharmacies and people with mental illness or history of drug and alcohol abuse.  Common points of risk include:

  • Procurement
  • Preparation and dispensing
  • Prescribing
  • Administration
  • Waste and removal

3) Engage leadership in all key components of controlled substance diversion prevention program (CSDPP): 

  • Core Administrative Elements:
    • Legal and regulatory requirements
    • Organization accountability and oversight
  • System Level Controls:
    • HR Management
    • Automation and technology
    • Monitory and surveillance
    • Investigation and reporting
  • Provider Level Controls:
    • Storage and security
    • Chain of custody
    • Internal pharmacy controls
    • Waste, returns and disposal


C2R Global Manufacturing, Inc. Provides CS Waste Disposal Compliance 

C2R Global Manufacturing, Inc. offers drug disposal compliance to healthcare facilities including hospitals, acute health and surgical facilities, pharmacies, long term care facilities, correctional facilities and any healthcare setting requiring the disposal of pharmaceuticals.  We offer free compliance consultations to qualified customers, education and training on-site as well as phone support.  We offer a wide selection of easy to use product sizes to meet any facility requirements with convenient drug disposal methods meeting DEA and EPA regulations.

C2R Global Manufacturing, Inc. provides simple to use drug disposal solutions with seamless facility implementation.  We are dedicated to saving water, saving lives…one prescription at a time with drug disposal compliance made easy.  Contact us to learn more about our compliant drug disposal solutions as part of your effective drug diversion prevention policy.